Viewing Study NCT00262431



Ignite Creation Date: 2024-05-05 @ 12:11 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00262431
Status: COMPLETED
Last Update Posted: 2012-06-08
First Post: 2005-12-05

Brief Title: Efficacy of Early Tracheostomy to Reduce Incidence of Ventilator Acquired Pneumonia VAP
Sponsor: University of Turin Italy
Organization: University of Turin Italy

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2012-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study aims to assess early one to three days after intubation tracheostomy effectiveness in terms of reduction in ventilator associated pneumonia VAP incidence
Detailed Description: Tracheostomy is an essential and irreplaceable procedure for critically ill patients requiring mechanical ventilatory support and adequate airway control The therapeutical choice of performing a tracheostomy is supported by a number of clinical benefits such as less use of drugs for sedation fewer days of mechanical ventilation and hence shorter Intensive Care Unit ICU length of stay as well as better resource rationalization Actually there is no agreement on the best timing for tracheostomy The aim of this study is to verify if an early tracheostomy one to three days after intubation increases ventilator associated pneumonia-free days Secondary endpoints are increase of ventilator free-days and mortality reduction

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None